The ABCC3 efflux pump, in the case of breast cancer cells, is associated with HER2 positive cells, which is the case of BT-747 cells [49], and has been associated to a decreased rate of drug retention and with chemoresistance [73]. The gene discussed is ABCC3; the disease is breast carcinoma.